Snehal Shah

Snehal Shah is an experienced leader in the pharmaceutical industry, currently serving as the President of Research & Development at Oculis since April 2024. Prior to this role, Snehal held various senior positions at Iveric Bio, including SVP, Chief Regulatory and Product Strategy Officer, and SVP, Chief Regulatory and Pharmacovigilance Officer from March 2021 to April 2024. Snehal's expertise in regulatory affairs and pharmacovigilance was further established during tenure as Senior Vice President at Kyowa Kirin, Inc. from February 2017 to March 2021, and as Executive Director at Noven Pharmaceuticals from May 2012 to January 2017. Earlier in the career, Snehal worked as a Program Director in Regulatory Affairs at Roche Pharmaceuticals from January 2007 to May 2012. Educational qualifications include a Doctor of Pharmacy (Pharm.D.) from The University of Kansas (2005-2007) and a Bachelor of Science (BS) in Pharmacy from Rutgers University (1996-2001).